Lenalidomide improvement of cisplatin antitumor efficacy on triple-negative breast cancer cells in vitro.
In conclusion, the present study provides the basis for using lenalidomide in combination with cisplatin in TNBC therapy.
PMID: 29616116 [PubMed]
Source: Oncology Letters - Category: Cancer & Oncology Tags: Oncol Lett Source Type: research